SpringerLink
Log in

The Immunization of Protoscolices P29 DNA Vaccine on Experimental Cystic Echinococosis in Balb/c Mice

  • Original Paper
  • Published:
Acta Parasitologica Aims and scope Submit manuscript

Abstract

Purpose

Cystic Echinococosis is one of the important parasitic diseases that is considered as a problem economics and health in many parts of the world. Many efforts have been performed for controlling the disease in the world. To reach a reliable vaccine against Cystic Echinococosis is one of the important duty of governments. Several antigen of hydatid cyst for vaccine candidate have been evaluated. In this study, P-29 antigen has been used for this purpose.

Methods

E.g P29 antigen was cloned in Escherichia coli and transfected into the Chinese hamster ovary cell for antigen proliferation and used for vaccination in Balb/c mice. The recombinant antigen E.g-29 was shown using Western blot test. Two dilution of DNA vaccine (pCEgP-29) including 50 µg/100 µl and 100 µg/100 µl were prepared. Twenty four Balb/C male 6–8 week mouse were divided in 4 groups. The groups were included in 2 vaccination groups (pcEg.P29 50 µg/100 µl and 100 µg/100 µl dilution) as immunized groups and 2 groups of plasmid and PBS as control. The mice were injected intramuscularly 3 times with 2 weeks interval. After 3 weeks from last injection, all groups were challenged intraperitonealy with 2000 protoscolices. After 5 months, the mice were euthanized by ketamine/xylasine injection and number, size, and weight of cysts were recorded.

Results

Immunization rate was up to 93% in vaccinated group when compared with the control group.

Conclusion

The results of this study showed that rEg.P29 could be considered as an effective vaccine for controlling of E. granulosus prevalence in intermediated host.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig.3
Fig. 4

Similar content being viewed by others

References

  1. Zhang W, Wen H, Li J, Lin R, McManus DP (2012) Immunology and immunodiagnosis of cystic echinococcosis: an update. Clin Dev Immunol. https://doi.org/10.1155/2012/101895

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mahmoudi S, Mamishi S, Banar M, Pourakbari B, Keshavarz H (2019) Epidemiology of echinococcosis in Iran: a systematic review and meta-analysis. BMC Infect Dis 19:929. https://doi.org/10.1186/s12879-019-4458-5

    Article  PubMed  PubMed Central  Google Scholar 

  3. Zhang W, Li J, You H, Zhang Z, Turson G, Loukas A et al (2003) Echinococcus granulosus from **njiang, PR China: cDNAs encoding the EG95 vaccine antigen are expressed in different life cycle stages and are conserved in the oncosphere. Am J Trop Med Hyg 68:40–43 (PMID: 12556145)

    Article  CAS  Google Scholar 

  4. Craig PS, McManus DP, Lightowlers MW, Chabalgoity JA, Garcia HH, Gavidia CM et al (2007) (2007) Prevention and control of cystic echinococcosis. Lancet Infect Dis 7:385–394

    Article  Google Scholar 

  5. Lightowlers M, Flisser A, Gauci C, Heath D, Jensen O, Rolfe R (2000) Vaccination against cysticercosis and hydatid disease. Parasitol Today 16:191–196. https://doi.org/10.1016/s0169-4758(99)01633-6

    Article  CAS  PubMed  Google Scholar 

  6. Wedrychowicz H (2015) Antiparasitic DNA vaccines in 21st century. Acta Parasitol 60:179–189. https://doi.org/10.1515/ap-2015-0026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Pourseif MM, Moghaddam G, Saeedi N, Barzegari A, Dehghani J, Omidi Y (2018) Current status and future prospective of vaccine development against Echinococcus granulosus. Biologicals 51:1–11. https://doi.org/10.1016/j.biologicals.2017.10.003

    Article  CAS  PubMed  Google Scholar 

  8. Kandil OM, Abdelrahman KA, Mahmoud MS, Mahdy OA, Ata EB, Aloufi AS et al (2020) Cystic echinococcosis: development of an intermediate host rabbit model for using in vaccination studies. Exp Parasitol 208:107800. https://doi.org/10.1016/j.exppara

    Article  CAS  PubMed  Google Scholar 

  9. Morariu S, Lightowlers MW, Cosoroabă I, Dărăbuș G, Bart JM, Ilie M et al (2010) Utilization of EG95 vaccine for sheep immunization against cystic echinococcosis in Romania. J Sci Parasitol 11:29–34

    Google Scholar 

  10. Lightowlers M, Jensen O, Fernandez E, Iriarte J, Woollard D, Gauci C et al (1999) Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. Int J Parasitol 29:531–534. https://doi.org/10.1016/s0020-7519(99)00003-x

    Article  CAS  PubMed  Google Scholar 

  11. Pirestani M, Dalimi A, Sarvi S, Khoramabadi N (2014) Evaluation of immunogenicity of novel isoform of EG95 (EG95-5G1) from Echinococcus granulosus in BALB/C mice. Iran J parasitol 9:491–502

    PubMed  PubMed Central  Google Scholar 

  12. González G, Spinelli P, Lorenzo C, Hellman U, Nieto A, Willis A et al (2000) Molecular characterization of P-29, a metacestode-specific component of Echinococcus granulosus which is immunologically related to, but distinct from, antigen 5. Mol Biochem Parasitol 105:177–185. https://doi.org/10.1016/s0166-6851(99)00166-8

    Article  PubMed  Google Scholar 

  13. Wang H, Li Z, Gao F, Zhao J, Zhu M, He X et al (2016) Immunoprotection of recombinant Eg. P29 against Echinococcus granulosus in sheep. Vet Res commun 40:73–79. https://doi.org/10.1007/s11259-016-9656-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ben Nouir N, Gianinazzi C, Gorcii M, Müller N, Nouri A, Babba H et al (2009) Isolation and molecular characterization of recombinant Echinococcus granulosus P29 protein (recP29) and its assessment for the post-surgical serological follow-up of human cystic echinococcosis in young patients. Trans R Soc Trop Med Hyg 103:355–364. https://doi.org/10.1016/j.trstmh.2008.09.020

    Article  CAS  PubMed  Google Scholar 

  15. Shi Z, Wang Y, Li Z, Li Z, Bo Y, Ma R et al (2009) Cloning, expression, and protective immunity in mice of a gene encoding the diagnostic antigen P-29 of Echinococcus granulosus. Acta Biochim Biophys Sin. https://doi.org/10.1093/abbs/gmn009

    Article  PubMed  Google Scholar 

  16. Khan KH (2013) DNA vaccines: roles against diseases. Germs 3:26–35. https://doi.org/10.11599/germs

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Mauel J (2002) Vaccination against leishmania infections. Curr Drug Targets Immune Endocr Metabol Disord 2:201–226. https://doi.org/10.2174/1568008023340631

    Article  CAS  PubMed  Google Scholar 

  18. Azizi H, Kazemi B, Bandehpour M, Mohebali M, Khamesipour A, Aryaeipour M et al (2016) Modulation of the immune response to DNA vaccine encoding gene of 8-kDa subunit of Echinococcus granulosus antigen B using murine interleukin-12 plasmid in BALB/c mice. Iran J Parasitol 11:480–488 (PMID: 28127359)

    PubMed  PubMed Central  Google Scholar 

  19. Sarvi S, Dalimi A, Ghafarifar F (2012) Molecular cloning and expression of EG95 gene of Iranian isolates of Echinococcus granulosus. Iran J Parasitol 7:1–7 (PMID: 23109939)

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Li ZJ, Wang YN, Qi W, Wei Z (2012) Echinococcus granulosus 14–3-3 protein: a potential vaccine candidate against challenge with Echinococcus granulosus in mice. Biomed Environ Sci 25:352–358. https://doi.org/10.3967/0895-3988.2012.03.014

    Article  CAS  PubMed  Google Scholar 

  21. Siles-Lucas M, Becerro-Recio D, SerratGonzalez-Miguel JJ (2020) J Fascioliasis and fasciolopsiasis: current knowledge and future trends. Res Vet Sci 17:27–35

    Google Scholar 

  22. Zhu M, Wang X, Wang H, Wang Z, Zhao J, Wang Y et al (2015) Mechanism of protective immunity by vaccination with recombinant Echinococcus granulosus glutathione S-transferase (Chinese strain) in mice. Exp Ther Med 10:1127–1132. https://doi.org/10.3892/etm.2015.2582

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zhu M, Gao F, Li Z, Wang X, Wang H, Wang Z et al (2016) Immunoprotection of recombinant Eg. myophilin against Echinococcus granulosus infection in sheep. Exp Ther Med 12:1585–1590. https://doi.org/10.3892/etm.2016.3501

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Poggio TV, Jensen O, Mossello M, Iriarte J, Avila HG, Gertiser ML et al (2016) Serology and longevity of immunity against Echinococcus granulosus in sheep and llama induced by an oil-based EG 95 vaccine. Parasite Immunol 38:496–502. https://doi.org/10.1111/pim.12325

    Article  CAS  PubMed  Google Scholar 

  25. Hashemi TGR, Razmi GR (2009) Antibody response against hydatid fluid, protoscolex and whole body of Echinococcus granulosus antigens in lambs. Iran J Vet Res (IJVR) 10:283–288. https://doi.org/10.22099/ijvr.2009.1710

    Article  Google Scholar 

  26. Valizadeh M, Haghpanah B, Badirzadeh A, Roointan E, Fallahi S, Raeghi S (2017) Immunization of sheep against Echinococcus granulosus with protoscolex tegumental surface antigens. Vet World 10:854–858. https://doi.org/10.14202/vetworld.2017.854-858

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Dempster RP, Harrison GBL, Berridge MV, Heath DD (1992) Echinococcus granulosus: use of an intermediate host mouse model to evaluate sources of protective antigens and a role for antibody in the immune response. Int J Parasitol 22:435–441

    Article  CAS  Google Scholar 

  28. Lin RY, Ding JB, Lu XM, Wang XF, Wei AXL et al (2004) Transient expression of Echinococcus granulosus Eg95 DNA vaccine and induction of immune response in mice. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 22:204–208

    PubMed  Google Scholar 

  29. Dutton S, Fleming SB, Ueda N, Heath DD, Hibma MH, Mercer AA (2012) Delivery of Echinococcus granulosus antigen EG95 to mice and sheep using recombinant vaccinia virus. Parasite Immunol 34:312–317

    Article  CAS  Google Scholar 

  30. Jafari SH, Esmaili Zad M, Rafiee A, Mesri R, Ahmad Zade M, Mohammadi S (2015) Evaluation of peptid EgP-29aa134-142 Immunogenicity derived from (Echinococcus granulosus) in BALB/C. Alborz Univ Med J 5:34–39. https://doi.org/10.18869/acadpub.aums.5.1.34

    Article  Google Scholar 

  31. Rahdar M, Rafiei A, Valipour-Nourooz R (2020) The combination of cytokines and albendazole therapy for prophylaxis and treatment of experimental hydatid cyst. Acta Trop 201:1–6. https://doi.org/10.1016/j.actatropica.2019.105206

    Article  CAS  Google Scholar 

  32. Brunetti E, Junghanss T (2009) Update on cystic hydatid disease. Curr Opin Infect Dis 22:497–502. https://doi.org/10.1097/QCO.0b013e328330331c

    Article  PubMed  Google Scholar 

  33. McManus DP, Gray DJ, Zhang W, Yang Y (2012) Diagnosis, treatment, and management of echinococcosis. BMJ 344:e3866. https://doi.org/10.1136/bmj.e3866

    Article  PubMed  Google Scholar 

  34. Boubaker G, Gottstein B, Hemphill A, Babba H, Spiliotis M (2014) Echinococcus P29 antigen: molecular characterization and implication on post-surgery follow-up of CE patients infected with different species of the Echinococcus granulosus complex. PLoS ONE. https://doi.org/10.1371/journal.pone.e98357

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The current study is extracted from Ph.D. degree thesis of Mrs. Zahra Gharibi and has been supported financially by Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Author information

Authors and Affiliations

  1. Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    Zahra Gharibi & Mahmoud Rahdar

  2. Parasitology Department, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    Zahra Gharibi, Mahmoud Rahdar & Mehdi Tavalla

  3. Parasitology and Medical Entomology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

    Majid Pirestani

  4. Basic Sciences Department, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran

    Mohammad-Reza Tabandeh

Authors
  1. Zahra Gharibi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mahmoud Rahdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Majid Pirestani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mehdi Tavalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohammad-Reza Tabandeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahmoud Rahdar.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gharibi, Z., Rahdar, M., Pirestani, M. et al. The Immunization of Protoscolices P29 DNA Vaccine on Experimental Cystic Echinococosis in Balb/c Mice. Acta Parasit. 66, 1114–1121 (2021). https://doi.org/10.1007/s11686-021-00367-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11686-021-00367-7

Keywords

Search

Navigation